Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fospropofol disodium versus propofol for recovery quality after total intravenous anesthesia
ChiCTR2400094928Phase 4Not yet recruiting
- Sponsor
- Affiliated Suzhou Hospital of Nanjing Medical University
- Start
- Dec 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of fospropofol disodium, propofol and sufentanil in None (2 arms), sponsored by Affiliated Suzhou Hospital of Nanjing Medical University. Primary endpoint: QoR-15 score at 24 hours postoperatively. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
fospropofol disodiumpropofolsufentanil
Beyond the preview
Go deeper on ChiCTR2400094928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094928.